Some researchers have reported that pathobiological events, most notably mTORC1 hyperactivity, which can be related to high-grade glioma, can increase Fe(III) uptake into cancer cells by regulating the activity of the transferrin receptor (TfR) in preclinical models [53]. Here, TFRC is linked to glioma.